VEGFA and cancer: Interestingly, microparticles have been also suggested as biomarkers and mediators of vascular dysfunction and hypertension commonly observed in cancer patients under treatment with vascular endothelial growth factor (VEGF) inhibitors (Neves et al., 2019).